IVD Market in China Worth $18.9 Billion by 2027 | New Diagnostic Requirements Constantly Emerging | Discover the Leading Trends, Opportunities and Market Segments
February 28, 2022 05:48 ET
|
Research and Markets
Dublin, Feb. 28, 2022 (GLOBE NEWSWIRE) -- The "China in Vitro Diagnostics Market, Size, Forecast 2022-2027, Industry Trends, Growth, Share, Impact of COVID-19, Company Analysis" report has been...
Rapid Micro Biosystems to Participate at the Cowen 42nd Annual Health Care Conference
February 23, 2022 16:45 ET
|
Rapid Micro Biosystems, Inc.
LOWELL, Mass., Feb. 23, 2022 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation...
Rapid Micro Biosystems to Announce Fourth Quarter and Full Year 2021 Financial Results on March 4, 2022
February 17, 2022 16:10 ET
|
Rapid Micro Biosystems, Inc.
LOWELL, Mass., Feb. 17, 2022 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (“Rapid Micro” or the “Company”), an innovative life sciences technology company providing mission...
IVD Contract Manufacturing Services (Assay Development, Manufacturing) Markets - Global Forecast to 2028
February 14, 2022 04:08 ET
|
Research and Markets
Dublin, Feb. 14, 2022 (GLOBE NEWSWIRE) -- The "IVD Contract Manufacturing Services Market by Type (Assay Development, Manufacturing), Category (Reagents, Systems), Technology (Immunoassay, Molecular...
IVD Market Brief Update Report 2021: What is the Size of the Market and the Major Trends Affecting it?
February 08, 2022 04:58 ET
|
Research and Markets
Dublin, Feb. 08, 2022 (GLOBE NEWSWIRE) -- The "IVD Market Brief Update" report has been added to ResearchAndMarkets.com's offering. What is the Size of the IVD Market in 2021? What Major Trends are...
Rapid Micro Biosystems Appoints Michael Beaulieu as Vice President, Investor Relations and Corporate Communications
January 20, 2022 16:30 ET
|
Rapid Micro Biosystems, Inc.
LOWELL, Mass., Jan. 20, 2022 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation...
In Vitro Diagnostic Market Brief Update 2021 - Featuring Agilent, bioMerieux and Hologic Among Others
January 20, 2022 06:58 ET
|
Research and Markets
Dublin, Jan. 20, 2022 (GLOBE NEWSWIRE) -- The "In Vitro Diagnostic Market Brief Update" report has been added to ResearchAndMarkets.com's offering. Diagnostic test products have never been more...
Provectus Biopharmaceuticals Announces Publication of Pharmaceutical-Grade Rose Bengal’s Activity Against Gram-Positive Bacteria
January 10, 2022 06:00 ET
|
Provectus Biopharmaceuticals Inc.
KNOXVILLE, TN, Jan. 10, 2022 (GLOBE NEWSWIRE) -- Provectus (OTCQB: PVCT) today announced that preclinical research on a formulation of the Company’s pharmaceutical-grade rose bengal against...
Rapid Micro Biosystems Announces Preliminary Unaudited Fourth Quarter and Full Year 2021 Revenue and Provides 2022 Revenue Outlook
January 09, 2022 18:00 ET
|
Rapid Micro Biosystems, Inc.
Full year 2021 commercial revenue expected to be between $21.3 million and $21.7 million Full year 2022 commercial revenue outlook between $27 million and $32 million Company to Present at the 40th...
BioMe Inc. and Yonsei Medical Center Sign Technology Transfer Contract for Pathbreaking Microbiome Treatment
December 29, 2021 11:00 ET
|
BioMe
SEOUL, South Korea, Dec. 29, 2021 (GLOBE NEWSWIRE) -- The microbiome treatment market is receiving global attention and is rapidly emerging as a new treatment alternative for various intractable...